April 2022 Newsletter

Published on 05/03/2022

12 min read

SOPHiA GENETICS analyzes one million genomic profiles

Having facilitated the analysis of one million genomic profiles, the SOPHiA DDM™ Platform has been exposed to a highly diverse array of genomic variants needed to continually hone machine learning algorithms for the accurate detection of rare and challenging cases.

J.P. Morgan Global Technology, Media, and Communications Conference

SOPHiA GENETICS to Attend and Host Investor Meetings at the J.P. Morgan 50th Annual Global Technology, Media, and Communications Conference

Check out our Science Hub

Get a closer look at the science behind what makes SOPHiA GENETICS technology unique.

Evolution of Precision Medicine

This blog examines the evolution of precision medicine and how we can achieve its promise. 

Innovation Symposium

Discover how we are unlocking the promise of data-driven medicine in cancer care, together. Register now to attend and receive updates about our ASCO presence.

pink dots icon

Upcoming Events

[facetwp template=”events_grid”]

pink dots icon

In The News

Inside Precision Medicine

SOPHiA GENETICS’ Data Driven Medicine Platform Hits One Million Genomic Profiles

Le Lézard

SOPHiA GENETICS Hits Milestone Of One Million Genomic Profiles Analyzed By The SOPHiA DDM Platform


AI Applications Address Challenges in Cancer Patient Screening

Pharma's Almanac

Q: What important company milestone do you anticipate reaching in 2022?

Pharma's Almanac

Q: What’s the key to being a leader in the industry?

pink dots icon

Want to know more?
Get in touch with us.

Our client services team is on hand to help.